Novavax Inc (NVAX)

EBITDA Margin

-75.72%

Quarterly · Period ending:

NVAX logo

NVAX EBITDA Margin

Latest reported-75.72%
NVAX Quarterly EBITDA Margin (-1000.00% → -75.72%)
High-resolution chart · PNG

NVAX ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Novavax Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
-75.7187%
-0.3892%
19.6087%
-271.0895%
50.3825%
80.0878%
-60.5576%
-124.7113%
43.2895%
-137.478%
-55.5327%
-531.6035%
16.7417%
4,346.033%
-59.9967%
-20.9134%
-266.835%
36.0049%
112.9386%
-171.6278%
-114.2187%
-47.6047%
-61.0826%
-122.0603%
-37.9706%
-648.2677%
-315.9142%
-548.8632%
-1,031.6056%
-960.1205%
-717.3005%
-505.8306%
-362.3132%
-423.3917%
-434.1049%
-449.6887%
-577.7332%
-673.0634%
-951.7133%
-1,873.1662%
-2,969.9401%
-1,727.5486%
-1,348.0608%
-482.8199%
-136.6748%
-233.1173%
-470.9102%
-226.9418%
-203.8625%
-179.4827%
-149.3827%
-303.2278%
-349.4194%
-248.0564%
-195.9264%
-118.8031%
-77.5869%
-151.4433%
-56.219%
-79.2332%
-197.3009%
-846.7626%
-8,705.8824%
-5,713.1429%
-121,685.7143%
-10,143.6364%
-18,728.3784%
-3,962.6866%
-25,937.931%
-32,585.7143%
-12,711.4286%
-5,010.3093%
-2,291.8129%
-1,530.786%
524.0064%
-677.3384%
-5,442.4051%
-1,173.503%
-470.9941%
-451.8022%
-731.1085%
-308.4421%
318.4492%
-67.6486%
-180.9503%
-768.1913%
-440.8113%
-231.5467%
-220.6988%
-131.9255%
-67.8854%
-62.052%
-191.1648%
-428.8945%
-271.3949%
-256.9518%
-110.3056%
-84.9852%
-34.9354%
-30.0318%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.